Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair
published in: Journal of Orthopaedic Research
date of publication: 2012-05-16
main subject: bone fracture
Cites articles 48
- 2006-04-01
Date
Title
Article - wd:Q36991448